LEHI, Utah, Oct. 8, 2024 /PRNewswire/ — Dr. David Bearss, CEO and Co-founder of Halia Therapeutics has been named an honoree of the 2024 PharmaVoice 100 list in the Standout Leaders category. This prestigious recognition spotlights the most inspiring leaders in the life sciences industry….
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
